Lopressor (metoprolol tartrate) NDC 30698-459

NDC codes

FDA NDC Directory

Product NDC (as listed)30698-459Labeler and product segments. Claims need a package NDC.

Product NDC at billing width30698-0459Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
30698-459-01	30698045901	100 TABLET in 1 BOTTLE (30698-459-01)Marketed from May 5, 2014

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Lopressor
Generic name (nonproprietary): metoprolol tartrate
Active ingredients: Metoprolol tartrate — 100 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Validus Pharmaceuticals LLC
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 017963
Marketing start: May 5, 2014
Listing expires: Dec 31, 2026
Other FDA classes: Adrenergic beta-Antagonists (Mechanism)
Identifiers: Product ID 30698-459_28c4fc69-5609-49ec-8fe5-4d7bc8f88288SPL ID 28c4fc69-5609-49ec-8fe5-4d7bc8f88288SPL set ID 0283bc9d-6998-493a-824a-d4c85f704111RxCUI 866511, 866513, 866514, 866516UNII W5S57Y3A5LUPC 0330698459010
Pharmacologic class: beta-Adrenergic Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N430698045901 followed by a unit qualifier and the quantity

Package 30698-0459-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Sep 14, 2023.

Indications (excerpt from the label)

1 IND ICATIONS AND USAGE LOPRESSOR is a beta-adrenergic blocker indicated for the treatment of: Hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. ( 1.1 ) Angina Pectoris. ( 1.2 ) Myocardial Infarction, to reduce the risk of cardiovascular mortality when used in conjunction with intravenous metoprolol therapy in patients with definite or suspected acute myocardial infarction in hemodynamically stable patients. ( 1.3 ) 1.1 Hypertension LOPRESSOR is indicated for the treatment of hypertension in adult patients, to lower blood pressure. Lowering blood pressure lowers the risk…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under NDA 017963

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 017963
Product	Strength	Form · route	Labeler	Product NDC
Lopressormetoprolol tartrate	Metoprolol tartrate 50 mg/1	TabletOral	Validus Pharmaceuticals LLC	30698-458